BCM
CSII

Bayesian Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bayesian Capital Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,200
Closed -$247K – 745
2016
Q4 		$247K Buy
10,200
+916
+10% +$22.5K 0.06% 472
2016
Q3 		$220K Buy
+9,284
New +$203K 0.14% 263

Other funds holding CSII

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Bayesian Capital Management's CSII Position: Q1 2017 in Review

Bayesian Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2017, closing a stake of 10,200 shares — an estimated $247K sold.

Bayesian Capital Management first reported a position in CSII in Q3 2016 and held it in 2 quarters. The position peaked at $247K in Q4 2016. 167 funds tracked by Wall St. Rank hold CSII as of Q1 2017.

  • Bayesian Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 10,200 Cardiovascular Systems, Inc. shares in Q1 2017, an estimated $247K.
  • Bayesian Capital Management first reported a position in Cardiovascular Systems, Inc. in Q3 2016 and held it in 2 quarters.
  • Bayesian Capital Management's Cardiovascular Systems, Inc. position peaked at $247K in Q4 2016.
  • 167 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2017.

Based on Bayesian Capital Management's 13F filing for Q1 2017, filed 15 May 2017.